| Product NDC: | 55154-2399 |
| Proprietary Name: | Nalbuphine Hydrochloride |
| Non Proprietary Name: | Nalbuphine Hydrochloride |
| Active Ingredient(s): | 10 mg/mL & nbsp; Nalbuphine Hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-2399 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070914 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19890203 |
| Package NDC: | 55154-2399-5 |
| Package Description: | 5 AMPULE in 1 BAG (55154-2399-5) > 1 mL in 1 AMPULE |
| NDC Code | 55154-2399-5 |
| Proprietary Name | Nalbuphine Hydrochloride |
| Package Description | 5 AMPULE in 1 BAG (55154-2399-5) > 1 mL in 1 AMPULE |
| Product NDC | 55154-2399 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nalbuphine Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19890203 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | NALBUPHINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |